Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Michela Guardascione
Correction To: A P53/miR-30a/Zeb2 Axis Controls Triple Negative Breast Cancer Aggressiveness
Cell Death and Differentiation
Cell Biology
Molecular Biology
FARMAPRICE: A Pharmacogenetic Clinical Decision Support System for Precise and Cost-Effective Therapy
Genes
Genetics
Related publications
miR‑30a Inhibits Epithelial‑mesenchymal Transition and Metastasis in Triple‑negative Breast Cancer by Targeting ROR1
Oncology Reports
Medicine
Cancer Research
Oncology
circGNB1 Facilitates Triple-Negative Breast Cancer Progression by Regulating miR-141-5p-IGF1R Axis
Frontiers in Genetics
Genetics
Molecular Medicine
Triple-Negative Breast Cancer
Long Non-Coding RNA ZEB2-AS1 Promotes the Proliferation, Metastasis and Epithelial Mesenchymal Transition in Triple-Negative Breast Cancer by Epigenetically Activating ZEB2
Journal of Cellular and Molecular Medicine
Molecular Medicine
Cell Biology
A Review of Triple-Negative Breast Cancer
Cancer Control
Medicine
Oncology
Hematology
MiR-34b Is Associated With Clinical Outcome in Triple-Negative Breast Cancer Patients
Diagnostic Pathology
Forensic Medicine
Medicine
Pathology
Histology
Triple Negative Breast Cancer: Breast Cancer Research in Evolution
Breast Disease
Medicine
Cancer Research
Oncology
MiR-33a Functions as a Tumor Suppressor in Triple-Negative Breast Cancer by Targeting EZH2
Cancer Cell International
Cancer Research
Oncology
Genetics
Triple Negative Breast Cancer: Heterogenous Disease
REVIEWS IN ONCOLOGY
